The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Diabetic Retinopathy: A Position Statement by the American Diabetes Association
Open accessAbstract
Diabetic retinopathy diagnostic assessment and treatment options have improved dramatically since the 2002 American Diabetes Association Position Statement (1). These improvements include the widespread adoption of optical coherence tomography to assess retinal thickness and intraretinal pathology and wide-field fundus photography to reveal clinically silent microvascular lesions. Treatment of diabetic macular edema is now achieved by intravitreous injection of anti–vascular endothelial growth factor agents, and the same drugs are now used for proliferative diabetic retinopathy. Improvements in medications and devices for the systemic therapy of diabetes have also improved the ability of patients to optimize their metabolic control. This Position Statement incorporates these recent developments for the use of physicians and patients. Diabetic retinopathy is a highly specific neurovascular complication of both type 1 and type 2 diabetes, the prevalence of which strongly correlates to both the duration of diabetes and level of glycemic control. A pooled meta-analysis involving 35 studies conducted worldwide from 1980 to 2008 estimated global prevalence of any diabetic retinopathy and proliferative diabetic retinopathy (PDR) among patients to be 35.4% and 7.5%, respectively (2). Diabetic retinopathy is the most frequent cause of new cases of blindness among adults aged 20–74 years in developed countries. Glaucoma, cataracts, and other disorders of the eye occur earlier and more frequently in people with diabetes. In addition to diabetes duration, factors that increase the risk of or are associated with retinopathy include chronic hyperglycemia (3,4), nephropathy (5), hypertension (6), and dyslipidemia (7). Intensive diabetes management with the goal of achieving near-normoglycemia has been shown in large prospective randomized studies to prevent and/or delay the onset and progression of diabetic retinopathy (8,9). Lowering blood pressure has been shown to decrease retinopathy progression in people with type 2 diabetes, although tight targets (systolic blood pressure <120 mmHg) do …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,094
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030398010 · Cited by 1,885
Cited by
Guidelines on Diabetic Eye Care
Wong, T. Y., Sun, J., Kawasaki, R., Ruamviboonsuk, P., Gupta, N., Lansingh, V. C., Maia, M., Mathenge, W., Moreker, S., Muqit, M. M. K., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.04.007 · Cited by 839
Self-citationScreening for diabetic retinopathy: new perspectives and challenges
Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, P., Peto, T., & Simó, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30411-5 · Cited by 671
Current understanding of the molecular and cellular pathology of diabetic retinopathy
Antonetti, D. A., Silva, P. S., & Stitt, A. W. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00451-4 · Cited by 645
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
Zaharia, O. P., Strassburger, K., Strom, A., Bönhof, G. J., Karusheva, Y., Antoniou, S., Bódis, K., Markgraf, D. F., Burkart, V., Müssig, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30187-1 · Cited by 600
Neurodegeneration in diabetic retinopathy: does it really matter?
Simó, R., Stitt, A. W., & Gardner, T. W. (2018) · Diabetologia · doi:10.1007/s00125-018-4692-1 · Cited by 591
Self-citationTreatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline
LeRoith, D., Biessels, G. J., Braithwaite, S. S., Casanueva, F. F., Draznin, B., Halter, J. B., Hirsch, I. B., McDonnell, M. E., Molitch, M. E., Murad, M. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00198 · Cited by 568
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citation11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s011 · Cited by 460
Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
Lin, K., Hsih, W., Lin, Y., Wen, C., & Chang, T. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13480 · Cited by 446
Sayres, R., Taly, A., Rahimy, E., Blumer, K., Coz, D., Hammel, N., Krause, J., Narayanaswamy, A., Rastegar, Z., Wu, D., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.11.016 · Cited by 418
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s011 · Cited by 398
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s011 · Cited by 395
Diabetes Control and Complications Trial Research Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1084 · Cited by 385
Bressler, N. M., Beaulieu, W. T., Glassman, A. R., Blinder, K. J., Bressler, S. B., Jampol, L. M., Melia, M., Wells, J. A., & for the Diabetic Retinopathy Clinical Research Network (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.6565 · Cited by 343
Early Detection of Diabetic Retinopathy Using PCA-Firefly Based Deep Learning Model
Gadekallu, T. R., Khare, N., Bhattacharya, S., Singh, S., Maddikunta, P. K. R., Ra, I.-H., & Alazab, M. (2020) · Electronics · doi:10.3390/electronics9020274 · Cited by 343
A deep learning system for predicting time to progression of diabetic retinopathy
Dai, L., Sheng, B., Chen, T., Wu, Q., Liu, R., Cai, C., Wu, L., Yang, D., Hamzah, H., Liu, Y., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02702-z · Cited by 339
10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s010 · Cited by 302
Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review
Bain, S. C., Klufas, M. A., Ho, A., & Matthews, D. R. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13538 · Cited by 299
Cell Atlas of The Human Fovea and Peripheral Retina
Yan, W., Peng, Y.-R., van Zyl, T., Regev, A., Shekhar, K., Juric, D., & Sanes, J. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-66092-9 · Cited by 283
Predicting the risk of developing diabetic retinopathy using deep learning
Bora, A., Balasubramanian, S., Babenko, B., Virmani, S., Venugopalan, S., Mitani, A., de Oliveira Marinho, G., Cuadros, J., Ruamviboonsuk, P., Corrado, G. S., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30250-8 · Cited by 270
Gaballa, S. A., Kompella, U. B., Elgarhy, O., Alqahtani, A. M., Pierscionek, B., Alany, R. G., & Abdelkader, H. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00843-z · Cited by 255
Pathophysiology of diabetic retinopathy: The old and the new
Kusuhara, S., Fukushima, Y., Ogura, S., Inoue, N., & Uemura, A. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0182 · Cited by 250
Pearce, I., Simó, R., Lövestam‐Adrian, M., Wong, D. T., & Evans, M. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13550 · Cited by 180
12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s012 · Cited by 177
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Callaghan, B. C., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s012 · Cited by 176
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gibbons, C. H., Giurini, J. M., Hilliard, M. E., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s012 · Cited by 169
Self-citationInterpretable and Fine-Grained Visual Explanations for Convolutional Neural Networks
Wagner, J., Köhler, J. M., Gindele, T., Hetzel, L., Wiedemer, J. T., & Behnke, S. (2019) · 2019 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2019.00931 · Cited by 144
Mu, Y., Bao, X., Eliaschewitz, F. G., Hansen, M. R., Kim, B. T., Koroleva, A., Ma, R. C. W., Yang, T., Zu, N., & Liu, M. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00388-1 · Cited by 133
Jani, P. D., Forbes, L., Choudhury, A., Preisser, J. S., Viera, A. J., & Garg, S. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.1150 · Cited by 127
Lipid nanoparticles for the posterior eye segment
Bonilla, L., Espina, M., Severino, P., Cano, A., Ettcheto, M., Camins, A., García, M. L., Souto, E. B., & Sánchez-López, E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010090 · Cited by 76
Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update
Lin, F.-L., Wang, P.-Y., Chuang, Y.-F., Wang, J.-H., Wong, V. H. Y., Bui, B. V., & Liu, G.-S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.029 · Cited by 74
Yoshida, Y., Joshi, P., Barri, S., Wang, J., Corder, A. L., O'Connell, S. S., & Fonseca, V. A. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108255 · Cited by 65
Automated Diagnosis and Grading of Diabetic Retinopathy Using Optical Coherence Tomography
Sandhu, H. S., Eltanboly, A., Shalaby, A., Keynton, R. S., Schaal, S., & El-Baz, A. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-23677 · Cited by 44
Dow, E. R., Khan, N. C., Chen, K. M., Mishra, K., Perera, C., Narala, R., Basina, M., Dang, J., Kim, M., Levine, M., et al. (2023) · Ophthalmology Science · doi:10.1016/j.xops.2023.100330 · Cited by 40
Mather, K. J., Bebu, I., Baker, C., Cohen, R. M., Crandall, J. P., DeSouza, C., Green, J. B., Kirkman, M. S., Krause-Steinrauf, H., Larkin, M., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108235 · Cited by 34
RAHMATI, M., SMITH, L., BOYER, L., FOND, G., YON, D. K., LEE, H., SOYSAL, P., PIYASENA, M. P., & PARDHAN, S. (2024) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2024.07.028 · Cited by 34
A New Approach to Staging Diabetic Eye Disease
Channa, R., Wolf, R. M., Simo, R., Brigell, M., Fort, P., Curcio, C., Lynch, S., Verbraak, F., Abramoff, M. D., Abramoff, M. D., et al. (2024) · Ophthalmology Science · doi:10.1016/j.xops.2023.100420 · Cited by 26
Self-citationMehra, A. A., Softing, A., Guner, M. K., Hodge, D. O., & Barkmeier, A. J. (2022) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2022.08.008 · Cited by 24
Panunzi, S., Pompa, M., Borri, A., Piemonte, V., & De Gaetano, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237215 · Cited by 21
Development and Validation of a Diabetic Retinopathy Risk Stratification Algorithm
Tarasewicz, D., Karter, A. J., Pimentel, N., Moffet, H. H., Thai, K. K., Schlessinger, D., Sofrygin, O., & Melles, R. B. (2023) · Diabetes Care · doi:10.2337/dc22-1168 · Cited by 17
Rudraraju, M., Narayanan, S. P., & Somanath, P. R. (2021) · Life · doi:10.3390/life12010033 · Cited by 15
Solela, G., Gessesse, H. A., Zegeye, H., Worku, A., & Leulseged, B. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01731-0 · Cited by 5
(2022) · PubMed · doi:10.14670/hh-18-427 · Cited by 4
Arevalo, J. F., Beatson, B., & for the Pan-American Collaborative Retina Study Group (PACORES) (2022) · Retina · doi:10.1097/iae.0000000000003226 · Cited by 2
Diabetic retinopathy treatment cascade and care continuum in the USA: a systematic review
Fu, J. J., Applebaum, S. S., Granados, A., & Nwanyanwu, K. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-117683 · Cited by 1
Metadata
- Authors
- Solomon, S. D., Chew, E., Duh, E. J., Sobrin, L., Sun, J. K., VanderBeek, B. L., Wykoff, C. C., & Gardner, T. W.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-02-13
- Volume
- 40
- Issue
- 3
- Pages
- 412-418
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2590312224
- Cited by
- 940
- References
- 59
- FWCI
- 59.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.